Indonesia, an archipelago nation that spans thousands of islands, has reported more than 860,000 confirmed cases of the coronavirus and 25,000 deaths in the past year, one of the largest outbreaks in Indonesia. Asia The government has cited two main ideas behind different vaccination practices.
Officials are concerned about what they describe as lack of adequate research on how the CoronaVac vaccine, developed by Chinese company Sinovac, could affect older recipients. The late-stage trial in Indonesia excluded participants over the age of 60, and officials have decided that vaccinating children may be the best way to reduce the spread of the virus.
Health Minister Budi Gunadi Sadikin said the government wanted to target. “Those who are likely to gain and spread”;
In Indonesia, that means prioritizing the working-age population, the majority of confirmed cases in the country. The launch is “focused on people who have to meet a lot of people as part of the event. “So I don’t want people to think this is just an economy. This is to protect people. “
Indonesia approved a Chinese vaccine for emergency use on Monday after announcing that a late-stage clinical trial showed 65.3 percent effective, the first country outside China to approve a shot. But a Brazilian analysis released this week reduced its effectiveness by just over 50 percent, raising concerns in a South American country that has experienced one of the world’s worst outbreaks and plans to rely heavily on CoronaVac for its campaign. Vaccine Like many countries, Indonesia has approved a number of vaccines, including those from Pfizer-BioNTech and AstraZeneca, which will be distributed later.
The government plans to vaccinate Sinovac for about 1.5 million health workers within the next month, Reuters reported. Police, military, teachers and civil servants will be prioritized before the broader vaccine is offered to adults under the age of 60.
Indonesia’s hope is to slow the community spread in young residents, they will continue to protect the elderly from infection from relatives or close people. Many families in Indonesia live in intergenerational households, where it is almost impossible for elderly relatives to be separated from younger family members.
Other countries, including the United States, England and France, have taken a different course, choosing to prioritize older residents first, the younger ones as more likely to have severe symptoms of the disease; and Died The outbreak has destroyed long-term care facilities in Europe and North America, raising a sense of urgency to protect the elderly first.
But as long as there is a valid epidemiological reason, there is no need for a right or wrong way to vaccinate the population, said Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security.
“There is controversy to be made about the drivers of diffusion in a given geographic area and getting them vaccinated to have faster herd immunity in subpopulations,” he said. “People think about immunity. Of the herd, and they think of the population as one, but it isn’t. We know some people are more motivated than others. ”
Jennifer Nuzzo, also a senior scholar at Johns Hopkins, said the choice to begin with targeting populations understood to transmit the virus “is a reasonable argument and one that some argue the United States should do.” She said
She said the dilemma faced by health workers as they began planning vaccination was to choose whether to use the prescribed dose early to reduce transmission or “to prevent people from becoming seriously ill and avoiding the disease”. Died “
If Indonesia succeeds in vaccinating more people who are thought to be more likely to transmit the virus “they will see a decrease in deaths,” Nuzzo said, she added, “it may take a lot of time” to see it. Those results, other countries are now prioritizing the oldest population priorities to see the rapid drop in deaths linked to the virus.
And efforts to reduce the spread and mortality through targeted vaccination of people who spread the virus are largely dependent on the hope that vaccines can help protect not only people but also people who live. But from developing a severe disease But from the transmission of the virus to others – a question that remains as experts. Wait and see how the number of cases changes as more and more people are receiving vaccines around the world.